Hamarneh et al show convincingly that fasting-induced downregulation of natural alkaline phosphatase in the gut leads to a defective gut barrier function. Interestingly this functional defect of the gut can be repaired by simply adding alkaline phosphatase to the drinking water of the animals.
Wat we do
We develop RESCAP for treatment of ageing-related diseases
RESCAP is the proprietary name for our medication based on the enzyme alkaline phosphatase (AP). AP exists since the earliest days of evolution, emphasizing its relevance for life. The protective levels of AP as present at young age, gradually decrease upon ageing. Supplementing these levels by RESCAP as shown in animal models strongly protects against age-related diseases.
Use op rescap
RESCAP has potential in a variety of age-related diseases
Frailty
RESCAP can switch off the age-related effects of Frailty in patients
Parkinson
RESCAP may turn Parkinson’s diseases into a “drug-manageable” chronic condition.
Diabetes
RESCAP restores decreasing levels of AP-enzyme activity, which is probably one of the root-causes of diabetes.
Alzheimer's
RESCAP may strongly reduce the burden of Alzheimer’s disease by slowing down its progression.
Read more about the use of RESCAP
Scientific breakthroughs in using AP for promoting health:
Intestinal alkaline phosphatase targets the gut barrier to prevent aging
Kuhn et al not only confirm that simply adding Alkaline phosphatase to the drinking water of normal mice improves their gut barrier function, and gut microflora, they also show that oral treatment with alkaline phosphatase increases their life span and health span by over 25%. For humans this would mean that they could reach a mean age of over 100 years!